HDAC-IN-29
HDAC-IN-29 (compound 13b) is a potent pan-HDAC inhibitor. HDAC-IN-29 shows antitumor activity[1].
Product Specifications
CAS Number
2695593-95-2
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-29.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=CC=C1)[C@H](CSCCCC(NO)=O)NC(C2=CC=CC=C2)=O
Molecular Formula
C20H23N3O4S
Molecular Weight
401.48
References & Citations
[1]Wang J, et al. Cysteine derivatives as acetyl lysine mimics to inhibit zinc-dependent histone deacetylases for treating cancer. Eur J Med Chem. 2021 Dec 5;225:113799.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401337 100 µg
PKA R2 (PRKAR2A) (NM_004157) Human Over-expression Lysate
Sign In for Pricing
View Details 
RDR-NTXI-Ra-01 96 Tests
Rat Cross Linked N-Telopeptide Of Type I Collagen (NTXI) ELISA Kit
Sign In for Pricing
View Details RDR-NTXI-Ra-02 48 Tests
Rat Cross Linked N-Telopeptide Of Type I Collagen (NTXI) ELISA Kit
Sign In for Pricing
View Details 
